6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
16m ago	E-Power Onboards Expert Engineers with Background in NVIDIA AI Solutions to Drive U.S. AIDC Growth
16m ago	Cineverse Brings Guillermo del Toro's Masterpiece Pan's Labyrinth Back to Cannes Film Festival to Celebrate the 20th Anniversary of the Film's World Premiere
17m ago	Legacy Housing Corporation Announces Timing of First Quarter 2026 Earnings Release and Conference Call
17m ago	Sigma Lithium to Release First Quarter 2026 Earnings Results on May 15, 2026
44m ago	NewtekOne, Inc. Selected for Emerging Company Pavillion at the 2026 Sohn New York Investment Conference

About

Mink Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Agenus to Provide First Quarter 2026 Financial Report and Corporate Update

MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer

MiNK Therapeutics and Memorial Sloan Kettering to Present Phase II Study of agenT-797 Combination in PD-1 Refractory Gastroesophageal Cancer at AACR 2026

MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy

MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference

How Mink Therapeutics, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Recent Videos

INKT STOCK : POTENTIAL SPIKE | MINK THERAPEUTICS STOCK

INKT STOCK : POTENTIAL SPIKE | MINK THERAPEUTICS STOCK

Apr 13, 2026

My MiNK Therapeutics Filing Insight: Going Concern Risk & Strategy

My MiNK Therapeutics Filing Insight: Going Concern Risk & Strategy

Apr 06, 2026

MiNK Therapeutics, Inc. (0001840229) (Filer) #Shorts

MiNK Therapeutics, Inc. (0001840229) (Filer) #Shorts

Apr 06, 2026

ZyVersa Therapeutics, Inc. (0001859007) (Filer) #Shorts

ZyVersa Therapeutics, Inc. (0001859007) (Filer) #Shorts

Apr 06, 2026

Community Chat

Ask AI